Back to Search Start Over

Enhanced CXCR4 Expression of Human CD8 Low T Lymphocytes Is Driven by S1P 4 .

Authors :
Burkard T
Dreis C
Herrero San Juan M
Huhn M
Weigert A
Pfeilschifter JM
Radeke HH
Source :
Frontiers in immunology [Front Immunol] 2021 Aug 24; Vol. 12, pp. 668884. Date of Electronic Publication: 2021 Aug 24 (Print Publication: 2021).
Publication Year :
2021

Abstract

Although the human immune response to cancer is naturally potent, it can be severely disrupted as a result of an immunosuppressive tumor microenvironment. Infiltrating regulatory T lymphocytes contribute to this immunosuppression by inhibiting proliferation of cytotoxic CD8 <superscript>+</superscript> T lymphocytes, which are key to an effective anti-cancer immune response. Other important contributory factors are thought to include metabolic stress caused by the local nutrient deprivation common to many solid tumors. Interleukin-33 (IL-33), an alarmin released in reaction to cell damage, and sphingosine-1-phosphate (S1P) are known to control cell positioning and differentiation of T lymphocytes. In an in vitro model of nutrient deprivation, we investigated the influence of IL-33 and S1P receptor 4 (S1P <subscript>4</subscript> ) on the differentiation and migration of human CD8 <superscript>+</superscript> T lymphocytes. Serum starvation of CD8 <superscript>+</superscript> T lymphocytes induced a subset of CD8 <superscript>Low</superscript> and IL-33 receptor-positive (ST2L <superscript>+</superscript> ) cells characterized by enhanced expression of the regulatory T cell markers CD38 and CD39. Both S1P <subscript>1</subscript> and S1P <subscript>4</subscript> were transcriptionally regulated after stimulation with IL-33. Moreover, expression of the chemokine receptor CXCR4 was increased in CD8 <superscript>+</superscript> T lymphocytes treated with the selective S1P <subscript>4</subscript> receptor agonist CYM50308. We conclude that nutrient deprivation promotes CD8 <superscript>Low</superscript> T lymphocytes, contributing to an immunosuppressive microenvironment and a poor anti-cancer immune response by limiting cytotoxic effector functions. Our results suggest that S1P <subscript>4</subscript> signaling modulation may be a promising target for anti-CXCR4 cancer immunotherapy.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2021 Burkard, Dreis, Herrero San Juan, Huhn, Weigert, Pfeilschifter and Radeke.)

Details

Language :
English
ISSN :
1664-3224
Volume :
12
Database :
MEDLINE
Journal :
Frontiers in immunology
Publication Type :
Academic Journal
Accession number :
34504486
Full Text :
https://doi.org/10.3389/fimmu.2021.668884